Posted on 01/03/2010 in Pharmaceutical Company Financials Grifols has reported its financial results for 2009, highlighting an improved sales performance when compared to the previous year.
The healthcare firm's sales total for the 12-month period finished at 913.2 million euros (822.6 million pounds), a year-on-year increase of 12.1 per cent.
According to the company's financial breakdown, this improved performance was due in part to its expansion into new global territories, as well as gains in key market sectors such as diagnostics and bioscience.
It was also able to record a growth in its hospital automation products division despite reduced market spending during the recession.
The company added: "Grifols' balance sheet remains solid, with net debt/equity ratio in 2009 at similar levels to 2008."
In January, the pharmaceuticals firm's charitable body Fundacion Probitas commenced its operations by outlining an aid plan for Haiti earthquake victims worth up to one million euros.Other news stories from 01/03/2010
Read more in the Zenopa News Archive
How this news is generated
|
